4-92304340-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000282020.9(GRID2):c.-317C>T variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0145 in 375,586 control chromosomes in the GnomAD database, including 265 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.031 ( 236 hom., cov: 32)
Exomes 𝑓: 0.0033 ( 29 hom. )
Consequence
GRID2
ENST00000282020.9 5_prime_UTR
ENST00000282020.9 5_prime_UTR
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.768
Genes affected
GRID2 (HGNC:4576): (glutamate ionotropic receptor delta type subunit 2) The protein encoded by this gene is a member of the family of ionotropic glutamate receptors which are the predominant excitatory neurotransmitter receptors in the mammalian brain. The encoded protein is a multi-pass membrane protein that is expressed selectively in cerebellar Purkinje cells. A point mutation in the mouse ortholog, associated with the phenotype named 'lurcher', in the heterozygous state leads to ataxia resulting from selective, cell-autonomous apoptosis of cerebellar Purkinje cells during postnatal development. Mice homozygous for this mutation die shortly after birth from massive loss of mid- and hindbrain neurons during late embryogenesis. This protein also plays a role in synapse organization between parallel fibers and Purkinje cells. Alternate splicing results in multiple transcript variants encoding distinct isoforms. Mutations in this gene cause cerebellar ataxia in humans. [provided by RefSeq, Apr 2014]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.52).
BP6
Variant 4-92304340-C-T is Benign according to our data. Variant chr4-92304340-C-T is described in ClinVar as [Benign]. Clinvar id is 1278181.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.105 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
GRID2 | NM_001510.4 | c.-317C>T | 5_prime_UTR_variant | 1/16 | ENST00000282020.9 | NP_001501.2 | ||
GRID2 | XM_017008122.3 | c.-317C>T | 5_prime_UTR_variant | 1/15 | XP_016863611.1 | |||
GRID2 | XM_024454024.2 | c.-317C>T | 5_prime_UTR_variant | 1/17 | XP_024309792.1 | |||
GRID2 | XM_047450133.1 | c.-317C>T | 5_prime_UTR_variant | 1/16 | XP_047306089.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GRID2 | ENST00000282020.9 | c.-317C>T | 5_prime_UTR_variant | 1/16 | 1 | NM_001510.4 | ENSP00000282020 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0310 AC: 4723AN: 152122Hom.: 236 Cov.: 32
GnomAD3 genomes
AF:
AC:
4723
AN:
152122
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome AF: 0.00327 AC: 730AN: 223346Hom.: 29 Cov.: 0 AF XY: 0.00278 AC XY: 340AN XY: 122174
GnomAD4 exome
AF:
AC:
730
AN:
223346
Hom.:
Cov.:
0
AF XY:
AC XY:
340
AN XY:
122174
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0311 AC: 4728AN: 152240Hom.: 236 Cov.: 32 AF XY: 0.0290 AC XY: 2156AN XY: 74438
GnomAD4 genome
AF:
AC:
4728
AN:
152240
Hom.:
Cov.:
32
AF XY:
AC XY:
2156
AN XY:
74438
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
11
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | May 12, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at